of patients have noted a slight elevation in temperature. Patients should be observed for at least 20 minutes after administration. Hypersensitivity reactions include hives, generalized urticaria, tightness of the chest, wheezing, hypotension and anaphylaxis. RhoGAM(R) and MICRhoGAM(R) contain a small quantity of IgA and physicians must weigh the benefit against the potential risks of hypersensitivity reactions. Patients who receive RhoGAM(R) and MICRhoGAM(R) for Rh-incompatible transfusion should be monitored by clinical and laboratory means due to the risk of a hemolytic reaction.
For more detailed information regarding the safe and effective use of RhoGAM(R) Brand, please visit www.RhoGAM.com.
About Ortho Clinical Diagnostics
Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, delivers the high-quality in-vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner. The company serves the global transfusion medicine community with donor screening and blood typing products to ensure every patient receives blood that's safe, the right type, and the right unit. Ortho Clinical Diagnostics also brings sophisticated information management, testing technologies, and automation and interpretation tools to clinical laboratories worldwide to help them run more efficiently and improve patient care. For more information, visit www.orthoclinical.com.
(1) Zimmerman D.R. Rh: The Intimate History of a Disease and its Conquest. New York, NY: MacMillan Publishing Company, May 1973.
Rho(D) Immune Globulin (Human)Page: 1 2 3 4 5 6 7 8 9 Related medicine news :1
|SOURCE Ortho-Clinical Diagnostics, Inc.|
Copyright©2009 PR Newswire.
All rights reserved
. Document Security Systems (Amex: DMC) Invites You to a Landmark Event2
. Less than one-third of women aware of landmark hormone therapy study, Stanford researcher finds3
. Pathway to cell death redefined in landmark study4
. Pathway to cell death redefined in landmark study5
. UCLA to lead local study center in landmark government study of child health6
. Landmark Report: Excess Body Fat Causes Cancer7
. In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack8
. Landmark trial to evaluate cardioprotective properties of insulin9
. Safeway Inc. and the Prostate Cancer Foundation to Fund Landmark Prostate Cancer Research Collaboration10
. Yale launches landmark VIRGO study of young women with heart disease11
. Hospital Launches Landmark Project in Emergency Medicine